AstraZeneca is developing an investigative anti-eosinophil monoclonal antibody benralizumab that can be administered subcutaneously in an at-home setting. Drug development in the severe asthma space ...
Washington, DC, April 12, 2018 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) and Allergy Standards Limited (ASL) announced that Sanitaire® EON™ ALLERGEN Upright Vacuum ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved Xolair for the reduction of allergic reactions in children and adults with immunoglobulin E ...
On the plus side, an IL-33 inhibitor called itepekimab appeared to help patients keep their asthma under control better than placebo, reported Michael Wechsler, MD, of National Jewish Health in Denver ...
The chronic, incurable illness afflicts 12,000 SCS students. It is the single most common reason for admissions at Le Bonheur. Last year, the Asthma and Allergy Foundation of America named Memphis the ...
November 14, 2025 / RedChip Companies will air interviews with Connect Biopharma Holdings Limited (Nasdaq:CNTB) and Bimergen Energy Corp. (OCTQB:BESS) on the RedChip Small Stocks, Big Money™ show, a ...
Dublin, April 20, 2020 (GLOBE NEWSWIRE) -- The "Asthma - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. Asthma Pipeline Insight, 2020 report outlays ...
GENEVA & MOSCOW--(BUSINESS WIRE)--Selexis SA and Generium JSC today announced that Genolar ®, Generium’s biosimilar of omalizumab, is now commercially available in Russia for the treatment of ...
Storms like the one that recently uprooted ancient trees and, at one point, plunged nearly 200,000 Memphians into a hell of heat and darkness are poised to worsen. As is the asthma that so many suffer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback